PriceSensitive

TILT Holdings Inc. (CSE:TILT) receives approval to expand its Massachusetts cultivation and manufacturing facility

Cannabis
CSE:TILT
02 March 2021 09:30 (EDT)

TILT Holdings (TILT) has received regulatory approval from the Massachusetts Cannabis Control Commission (CCC) to commence the operation of eight additional grow rooms at its subsidiary, Commonwealth Alternative Care, Inc.

The company intends to begin cultivation operations in the newly approved space later this month.

“We are pleased to announce the regulatory approval of the second phase of the planned expansion of our 117,000 sq ft cultivation and manufacturing facility in Taunton, Massachusetts,” said Gary Santo, president of TILT.

“We now have more than 56,000 sq. ft. of cultivation space with the ability to add a second grow tier to each of the eight new rooms, pending regulatory approval.

Once planted, these additional rooms will fortify the supply of premium flower for our Taunton dispensary, and together with our award-winning kitchen and state-of-the-art extraction and processing lab, will support the production and distribution of high-quality, consistent products for our brand partners.

As we continue to solidify CAC’s presence in the state, we remain committed to working with the CCC to achieve final state licenses permitting medical dispensary operations at our Brockton and Cambridge locations, as well as adult-use operations at both our Brockton and Taunton locations.”

Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 35 states in the U.S., as well as Canada, Israel, Mexico, South America and the European Union.

Headquartered in Phoenix, TILT’s core businesses include Jupiter Research LLC, Commonwealth Alternative Care, Inc. in Massachusetts and Standard Farms, LLC in Pennsylvania.

TILT Holdings (TILT) is unchanged, trading at C$0.73 per share at 9:30 am EST.

Related News